Evaluation of the Expression Time of Ganciclovir-Induced Adverse Events Using JADER and FAERS-Reference-Cited by-同舟云学术

Evaluation of the Expression Time of Ganciclovir-Induced Adverse Events Using JADER and FAERS

Published:2019-11-01 Issue:11 Volume:42 Page:1799-1804
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Ando Go¹,Taguchi Kazuaki²,Enoki Yuki²,Yokoyama Yuta¹,Kizu Junko¹,Matsumoto Kazuaki¹²

Affiliation:

1. Division of Practical Pharmacy, Keio University Faculty of Pharmacy

2. Division of Pharmacodynamics, Keio University Faculty of Pharmacy

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/42/11/42_b19-00156/_pdf

Reference20 articles.

1. 1) Hara A, Matsumoto K, Yokoyama Y, Kizu J. Factorial analysis of hepatitis B virus reactivation-induced hepatitis B using JADER. Biol. Pharm. Bull., 40, 782–788 (2017).

2. 2) Ando G, Matsumoto K, Yokoyama Y, Kizu J. A survey on drug-related traffic accidents using an Adverse Drug Event Report database (JADER). J. Japanese Counc. Traffic Sci., 16, 46–50 (2016).

3. 3) Nakao S, Hatahira H, Sasaoka S, Hasegawa S, Motooka Y, Ueda N, Abe J, Fukuda A, Naganuma M, Kanoh H, Seishima M, Ishiguro M, Kinosada Y, Nakamura M. Evaluation of drug-induced photosensitivity using the Japanese Adverse Drug Event Report (JADER) database. Biol. Pharm. Bull., 40, 2158–2165 (2017).

4. 4) Fujita T. Signal detection of adverse drug reactions. Japanese J. Pharmacoepidemiol., 14, 27–36 (2009).

5. 5) Yue Z, Shi J, Li H, Li H. Association between concomitant use of acyclovir or valacyclovir with NSAIDs and an increased risk of acute kidney injury: data mining of FDA adverse event reporting system. Biol. Pharm. Bull., 41, 158–162 (2018).

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pharmacovigilance study on clinical factors of active vitamin D3 analog-related acute kidney injury using the Japanese Adverse Drug Event Report Database;Scientific Reports;2024-09-12

2. Drug-Induced Gynecomastia: Data Mining and Analysis of the FDA Adverse Event Reporting System Database;Clinical Epidemiology;2024-09

3. Long-term hepatobiliary disorder associated with trastuzumab emtansine pharmacovigilance study using the FDA Adverse Event Reporting System database;Scientific Reports;2024-08-23

4. SARS-CoV-2 mRNA vaccine-related myocarditis and pericarditis: An analysis of the Japanese Adverse Drug Event Report database;Journal of Infection and Chemotherapy;2024-08

5. Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients;DARU Journal of Pharmaceutical Sciences;2024-04-26